A common drug for high blood pressure has been mislabelled, prompting people who take it being urged to check their medication to ensure their dosage is correct, reports The Standard. One batch of the ...

The Medicines and Healthcare Products Regulatory Agency (MHRA) says some packs of lercanidipine, manufactured by Recordati ...

GSK plc has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Blenrep. In the UK, ...

The warning from the Medicines and Healthcare products Regulatory Agency (MHRA) comes after the manufacturer informed them of ...

Maine Democrats took a step toward constitutionalizing trans athletes' protections the day after the DOJ announced a lawsuit against the state over the issue.

An alert has been issued warning patients to check their medication after a misprint "error" on packaging. The "urgent" ...

GSK's Blenrep (belantamab mafodotin) has officially been approved by the UK's Medicines and Healthcare products Regulatory ...

Patients who take a common drug for high blood pressure are being urged to check the medication after its manufacturer ...

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday authorized GSK plc’s (NYSE:GSK) Blenrep.

Patients who take the common blood pressure medicine Lercanidipine HCI 20 mg tablets (lercanidipine hydrochloride) from the ...

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...